PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CEN | Ann: March 2024 Operating Report | 17/04/24 | 0 | 131 | |||
|
|||||||
CEN | Ann: Tauhara commissioning progress update | 28/03/24 | 0 | 168 | |||
|
|||||||
CEN | Ann: Application for quotation of securities - CEN | 18/03/24 | 0 | 108 | |||
|
|||||||
CEN | Ann: February 2024 Operating Report | 18/03/24 | 0 | 209 | |||
|
|||||||
CEN | Ann: Update to gas supply forecast | 07/03/24 | 0 | 137 | |||
|
|||||||
CEN | Ann: Update - Dividend/Distribution - CEN | 07/03/24 | 0 | 162 | |||
|
|||||||
CEN | Ann: Dividend/Distribution - CEN | 19/02/24 | 0 | 188 | |||
|
|||||||
CEN | Ann: FY24 Interim Results Presentation | 19/02/24 | 0 | 196 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |